Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin by Hyun-Ji Cho et al.
Cho et al. Proteome Science 2013, 11:20
http://www.proteomesci.com/content/11/1/20RESEARCH Open AccessComparative proteome analysis of Tumor necrosis
factor α-stimulated human Vascular Smooth
Muscle Cells in response to melittin
Hyun-Ji Cho1†, Jeong-Han Kang2†, Kwan-Kyu Park1, Jung-Yoon Choe1, Yoon-Yub Park1, Yong-Suk Moon1,
Il-Kyung Chung3, Hyeun-Wook Chang4, Cheorl-Ho Kim5, Yung Hyun Choi6, Wun-Jae Kim7, Sung-Kwon Moon8
and Young-Chae Chang1*Abstract
Background: Bee venom has been used to relieve pain and to treat inflammatory diseases, including rheumatoid
arthritis, in humans. To better understand the mechanisms of the anti-inflammatory and anti-atherosclerosis effect
of bee venom, gel electrophoresis and mass spectrometry were used to identify proteins whose expression was
altered in human Vascular Smooth Muscle Cells (hVSMCs) stimulated by tumor necrosis factor alpha after 12 h in
the presence of melittin.
Results: To obtain valuable insights into the anti-inflammatory and anti-atherosclerosis mechanisms of melittin,
two-dimensional (2-D) gel electrophoresis and MALDI-TOF/TOF were used. The proteome study, we showed 33
significant proteins that were differentially expressed in the cells treated with tumor necrosis factor alpha and
melittin. Thirteen proteins were significantly increased in the cells treated with tumor necrosis factor alpha, and
those proteins were reduced in the cells treated with melittin. Five of the proteins that showed increased
expression in the cells treated with tumor necrosis factor alpha are involved in cell migration, including calreticulin,
an essential factor of development that plays a role in transcription regulation. The proteins involved in cell
migration were reduced in the melittin treated cells. The observed changes in the expression of GRP75, prohibitin,
and a select group of other proteins were validated with reverse transcribed-PCR. It was confirmed that the
observed change in the protein levels reflected a change in the genes level. In addition, the phosphorylation of
EGFR and ERK was validated by analyzing the protein pathway.
Conclusion: Taken together, these data established that the expression of some proteins was significantly changed
by melittin treatment in tumor necrosis factor alpha stimulated the cells and provided insights into the mechanism
of the melittin function for its potential use as an anti-inflammatory agent.Background
The migration and proliferation of human Vascular
Smooth Muscle Cells (hVSMCs) are the major causes of
the development of advanced lesions in atherosclerosis
[1]. The migration and proliferation of hVSMCs is
caused by pathological phenomena such as the accumu-
lation of inflammatory cells and the release of pro-* Correspondence: ycchang@cu.ac.kr
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reproduction in any medium, provided the orinflammatory cytokines [1,2]. Pro-inflammatory cyto-
kines such as the tumor necrosis factor (TNF)-α have
various acts that mediate inflammation, and atherogen-
esis. Especially, TNF-α is a cytokine that is involved in
systemic inflammation. Thus, the primary role of TNF-α
is the regulation of immune cells. Moreover, TNF-α can
induce apoptotic cell death, and inhibit tumorigenesis
and viral replication [3]. On the other hand, the
dysregulation of TNF-α production has been implicated
in several of human diseases, as well as in atheroscler-
osis and cancer [2]. Therefore, hVSMCs and TNF-α de-
cisively promote atherosclerosis and inflammation.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of active peptides that include melittin, phospholipase
A2, apamin, adolapin, hyaluronidase, dopamine, and the
protease-inhibitor. It has been used in many studies on
the biological and pharmacological activities that have
anti-inflammatory effects on rheumatoid arthritis [4,5].
In addition, BV affects pain release, and immune modu-
latory activity [6]. It has also, been reported to have in-
duced apoptosis and suppressed the signaling pathway
in leukemic cells and renal cancer [7,8]. The major com-
pound of BV is melittin, a 26 amino acid peptide, which
forms an amphipathic helix with a highly charged carb-
oxyl terminus [9]. It comprises 52% of BV peptides [10].
Melittin reportedly has multiple effects, such as antibac-
terial, antivirus, and anti-inflammatory effects, in various
cell types [11,13]. In addition, it has been reported to be
capable of cell cycle arrest, growth inhibition, and apop-
tosis in various tumor cells [12,13]. However, the mecha-
nisms of the anti-atherosclerosis and anti-inflammatory
effects of melittin have not yet been fully explained.
Thus, the proteomics method was used to understand
the mechanisms of melittin in inflammation-induced
hVSMCs. Such studies can be facilitated by comparing
the obtained gels, with the 2-DE reference gels
representing the typical pattern of the cells being studied
under normal conditions. The association of 2-D elec-
trophoresis with MALDI-TOF-TOF mass spectrometry
and database interrogations enabled the identification of
33 proteins that were differentially expressed in the
hVSMCs after melittin treatment. In particular, various
proteins were implicated in the inflammation, regulation
of the protein folding, oxidation reduction, and signal
transduction.Results
Detection of the differentially expressed proteins in the
hVSMCs
To determine the changes in the protein expression after
the treatment of the cells with TNF-α or melittin, we
used 2-D gel electrophoresis to separate the total cell
proteins from the hVSMCs. Each gel was loaded with
400 μg of protein. Approximately 1,000 individual spots
were resolved in this manner. It was expected that many
individual spots would contain more than one protein
and this was borne out by the subsequent analysis using
mass spectrometry. It was also found in a number of in-
stances that the same protein was present in multiple
spots and was most likely the product of the post-
translational modifications or alternative splicing at the
mRNA level. Nevertheless, an estimated 900 individual
proteins at least were resolved, which provided a repre-
sentative samples of the cellular proteins and allowed
identification of many differentially expressed proteins.Three gels per sample were processed simultaneously
and analyzed with PDQUEST 2-D software to quantita-
tively compare the proteins that were recovered from
the treated cultures with those from the untreated cells.
Figure 1A and B show enlarged views of the gel regions
that contained spots whose staining intensity was, sig-
nificantly increased and decreased, respectively, after the
TNF-α or melittin treatment.Identification of the differentially expressed proteins
with MS
The protein spots from the 2-D gels were subjected to
trypsin digestion and MALDI-TOF-TOF analysis. Pro-
tein was definitively identified in 33 of the 52 spots that
showed significant changes, after the melittin treatment.
Several proteins were identified multiple times because
they were present in more than one spot. Table 1 lists
the proteins with the significantly differential expres-
sions, which had staining intensity ratios in the samples
from the treated and untreated cells were ≥ 1.5 or ≤ 0.6.
More than 95% of the spots had more than 10% se-
quence coverage and were identified with a 95% confi-
dence level. The identities of many of the proteins were
further validated by the agreement between their appar-
ent molecular weights and the isoelectric points that
were estimated from the positions of the identified
proteins in the 2-D gels and their theoretical values
(Mr < 20% or pI < 0.5).
The proteins were classified according to their mo-
lecular functions using the Panther Classification System
(www.pantherdb.org) and according to their categories
based cellular locations using the classifications from the
Swiss-Prot/TrEMBL protein knowledge base. The distri-
bution of the proteins into the different classes is
depicted in the bar graph in Figure 2A. The functional
categories with the highest representativeness were
transferase (~18%), the enzyme modulator (17%), and
oxidoreductase (10%). In addition, 65% of the proteins
were localized in the cytoplasm (Figure 2B).Protein pathway analysis of the differential expression
protein in the TNF-α treated cells
To provide some insights into the cellular activities that
were affected by the TNF-α or melittin treated cells, a
pathway analysis was performed to place the proteins into
different functional networks. As shown in Figure 3A, the
22 proteins that are involved in lipid metabolism, small
molecule biochemistry and cellular movement were
grouped together. In addition, the 11 proteins that are
involved in developmental disorder, skeletal and muscular
disorders, and cancer were grouped together (Figure 3B).
Therefore, selected IPA results were validated using
biochemical techniques.
Figure 1 (See legend on next page.)
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Figure 1 Expression of select proteins in hVSMCs following treatment with TNF-α or melittin. Whole cell extracts (400 μg of protein) were
prepared from hVSMCs cultured with TNF-α or melittin. Proteins from each culture were separated in parallel by two-dimensional SDS-PAGE.
Enlarged images of the spots containing proteins with increased expression in TNF-α-treated cells are shown in panel A; images of spots
containing proteins with decreased expression in melittin-treated cells are shown in panel B.
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To confirm the changes in the protein expression after
the melittin treatment, RT-PCR analysis was performed
to measure the changes in the corresponding mRNAs.
As shown in Figure 4A, the levels of four genes were re-
duced when the cells were treated with TNF-α and the
levels of all these four genes increased when melittin
added. Additionally, the mRNA expressions of prohibitin
and HSP60 did not change when only melittin added.
The expressions of GRP75 and annexin 1 increased
more significantly than those of the non-stimulated cells,
however, when only added with melittin (Additional file
1A). In contrast, the level of calriticulin was increased in
the TNF-α treated cell and did not change when cells
were treated with melittin (Additional file 1A). The
mRNA measurements confirmed that the changes were
observed by staining following the 2-D gel electrophor-
esis reflected changes in the protein levels. The analysis
of the protein pathway in the melittin-treated cells also
showed the phosphorylation of EGFR, and ERK and the
expression of NF-κB. As shown in Figure 4B, the
melittin treatment reduced the phosphorylation of
EGFR, and ERK and the expression of NF-κB in nuclear.
Moreover, they were reduced more significantly than
the cells that were not-stimulated cells by melittin
(Additional file 1B). Therefore, it is suggested that
melittin blocks the level of genes and the activity of
kinases.Discussion
BV has been widely used to relieve pain and treat in-
flammation in various chronic inflammatory diseases,
such as rheumatoid arthritis and multiple sclerosis. A
major compound of BV, melittin is the principal active
component of BV and is a powerful stimulator of
phospholipase A2. It also inhibits various protein ki-
nases and is a cell membrane lytic factor. It has also
shown potent anti-microbial activity and suppression of
infections [14,15].
In this study, a proteomics analysis of hVSMCs treated
with TNF-α or melittin was first performed to identify
differentially expressed proteins that are highly affected
by melittin in TNF-α stimulated cells. This technique re-
vealed 52 differentially expressed proteins and identified
33 significantly differentially expressed proteins whose
expressions had consistently different patterns after
TNF-α or melittin treatment. Many of the identifiedproteins were Stress-70 protein and Annexin A1, which
are involved in anti-apoptosis.
Prohibitin 1 (PHB) is multifunctional protein that is
localized in cells and mitochondrial membranes as well
as in the nucleus [16,17]. It is implicated in cellular pro-
cesses such as the mitochondrial function and protein
folding [18], transcription regulation [19] and prolifera-
tion control and suppression of oncogenesis [20,21]. Ex-
pression of PHB decreases during ulcerative colitis and
Crohn’s disease, two forms of inflammatory bowel dis-
ease [22,23]. In this study, prohibitin expression was
down-regulated in TNF-α treated cells and up- regulated
in melittin treated cells.
Annexins have been diversely implicated in cell differ-
entiation and proliferation, extracellular processes such
as coagulation, and membrane fusion events such as
endocytosis and exocytosis [24]. In addition, annexins
are intracellular molecules that are implicated in the
down-regulation of inflammation. Annexin-1 was identi-
fied recently as a secreted molecule and suggested as a
potent inhibitor of inflammation both in vitro, and
in vivo. Studies have indicated that annexin-1 is secreted,
and subsequent reports have shown that secreted
annexin-1 participates in additional anti-inflammatory
effects such as detachment of neutrophils from the
vascular endothelium [25,26]. In this study, annexin-1
expression was restored in melittin-treated hVSMCs and
melittin was suggested as having anti-inflammatory
effects.
Calreticulin binds unfolded glycosylated proteins in
the ER and is implicated in many cellular functions such
as lectin-like chaperoning, Ca2+ storage and signaling,
regulation of gene expression, cell adhesion, wound
healing and auto-immunity. Its over-expression on the
surface of lung fibroblasts has been reported in response
to cytomegalovirus infection [27,28]. Calreticulin was
up-regulated by TNF-α and down-regulated in the
melittin-treated hVSMCs.
Conclusion
This is the first report of the proteomic analysis of the
effects of melittin treatment on cultured hVSMCs. In
this study, the anti-inflammatory mechanism of melittin
on the inflammatory process was discovered. And sev-
eral target molecular of inflammation and proliferation
such as prohibitin, annexin-1 and calreticulin were iden-
tified. In addition, we found that two major protein
pathways using bioinformatics method. The protein
Table 1 Proteins showing differential expression in hVSMCs in response to melittin




1 Q15257 Serine/threonine-protein phosphatase
2A regulatory subunit
C Apoptosis 560 40 5.6 1.603 0.903
2 Q9Y3V2 RWD domain-containing protein 3 C Protein binding 400 30 6 1.589 0.857
3 P38646 Stress-70 protein M Anti-apoptosis 67833 73 5.9 0.555 1.026
4 Q9UJX0 Oxidative stress-induced growth inhibitor 1 C Ccell growth 112 60 7 3.456 0.47
5 O75439 Mitochondrial-processing peptidase subunit
beta
M Proteolysis 138 54 6.4 0.331 1.597
6 O75208 Ubiquinone biosynthesis protein COQ9 M Ubiquinone
biosynthesis
151 35 5.6 0.615 1.579
7 Q99518 Dimethylaniline monooxygenase ER Oxidoreductase 161 60 8.6 0.434 1.571
8 P10809 60 kDa heat shock protein M Chaperone 730 61 5.7 0.553 1.094
9 Q8N987 N-terminal EF-hand calcium-binding protein 1 C Calcium ion binding 404 40 4.8 1.7 0.229
10 Q96AB6 Protein N-terminal asparagine amidohydrolase C Hydrolase 112 34 5.8 0.235 0.688
11 P08754 Guanine nucleotide-binding protein G(k)
subunit alpha
C Transducer 1704 40 5.5 1.631 0.782
12 P27797 Calreticulin precurso ER Signal transducer
activity
183 48 4.3 2.225 0.362
13 Q9H361 Polyadenylate-binding protein 3 C Poly(A) RNA binding 156 70 9.7 8.041 0.25
14 Q6IQ49 Uncharacterized protein C1orf55 Unknown Unknown 4333 49 5.8 0.45 1.604
15 Q9NPA1 Calcium-activated potassium channel subunit
beta-3
CM Transport 920 31 6.9 0.589 2.289
16 Q9Y603 Transcription factor ETV7 N Repressor 142 38 8.3 3.929 0.39
17 Q17RB8 LON peptidase N-terminal domain and RING
finger protein 1
M Proteolysis 133 47 5.6 0.614 1.261
18 P35232 Prohibitin M DNA replication 1501 29 5.6 0.567 1.581
19 Q9Y262 Eukaryotic translation initiation factor 3
subunit E-interacting protein
C Initiation factor 1001 66 5.9 1.623 1.01
20 Q9Y512 Sorting and assembly machinery component
50 homolog
M Protein binding 303 51 6.4 0.194 0.632
21 Q9Y3Q3 Transmembrane emp24 domain-containing
protein 3 precursor
G Transport 1306 24 5.4 0.532 1.024
22 Q15080 Neutrophil cytosol factor 4 C Immune response 116 39 6.4 0.352 0.985
23 Q12792 Twinfilin-1 C Regulation of actin
phosphorylation
177 42 6.5 0.03 2.558




219 43 5.6 0.504 1.865
25 Q15080 Neutrophil cytosol factor 4 C Immune response 104 39 6.4 0.881 1.703
26 Q8N3R9 MAGUK p55 subfamily member 5 C Tight junction assembly 3244 77 5.8 4.311 1.148
27 P06753 Tropomyosin alpha-3 chain C Actin binding 179 32 4.7 1.534 0.473
28 P14550 Alcohol dehydrogenase C Oxidoreductase 173 36 6.3 1.722 0.876
29 Q5TZF3 Ankyrin repeat domain-containing protein 45 C Unknown 2335 31 4.6 0.739 2.151
30 Q16222 UDP-N-acetylhexosamine pyrophosphorylase C Transferase 193 58 5.9 4.854 0.304
31 P04083 Annexin A1 C Anti-apoptosis 271 38 6.6 0.6 1.442
32 P51580 Thiopurine S-methyltransferase C Transferase 150 28 5.8 0.051 1.518
33 O14618 Copper chaperone for superoxide dismutase C Chaperone 137 29 5.3 0.423 1.27
a The Swiss-Prot/TrEMBL database accession number. b protein score greater than 100 are significant (p < 0.05). CM: Cell membrane, ER: Endoplasmic reticulum,
M: Mitochondrion, N: Nucleus, C: Cytoplasm, G: Golgi apparatus, L: Lysosome, S: Secreted, MC: Microtubule.
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Figure 2 Classification of the proteins showing differential expression. Bar graph representing the distribution of the 33 identified proteins
according to their biological function, panel A, and cellular localization, panel B. Assignments were made based on information from the NCBI
(www.ncbi.nlm.nih.gov/PubMed) and the Swiss-Prot/TrEMBL protein knowledgebase (http://au.expasy.org/sport) websites.
Figure 3 Network pathway analysis of the differential expressed proteins melittin treatment. Proteins are grouped as being (A) primarily
involved in lipid metabolism, small molecule biochemistry, cellular movement, (B) primarily involved in developmental disorder, skeletal and
muscular disorders, cancer. Proteins shaded in red showed a ≥ 1.5-fold increase in abundance in melittin treated cells. Proteins shaded in green
showed a ≤ 0.6-fold decrease in abundance in melittin treated cells. The color intensity denotes the degree of abundance. Proteins were
identified through the ingenuity Knowledge Base. The shapes denote the molecular class of the protein. Solid line indicates a direct
molecular interaction.
Cho et al. Proteome Science 2013, 11:20 Page 6 of 9
http://www.proteomesci.com/content/11/1/20
Figure 4 Validation of the two-dimensional-PAGE data by quantitative RT-PCR and Validation of the protein pathway analysis data.
A, expression of selected genes in hVSMCs treated with TNF-α or melittin for 12 h was determined by quantitative RT-PCR. Total RNA was isolated
from hVSMCs, reverse transcribed and amplified with the specific primers indicated in under “materials and methods.” β-actin was used as the
control. B, Total cell lysates (25 μg) and nuclear lysates of hVSMCs treated for 12 h with either TNF-α or melittin were separated by SDS-PAGE.
Proteins were blotted onto a PVDF membrane, probed with specific antibodies, and detected as described under “materials and methods.”
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main molecular of inflammation in hVSMCs treated
with TNF-α or melittin. It was consistent with other
study. Jijon HB et al. reported that TNF-α induced ERK
and EGFR activation [29] and Andrianifahanana M et al.
reported that TGF-β induced EGFR activation [30].
According these reports, we suggest that TNF-α induced
ERK/NF-kb and EGFR. We believe that this experiment
would improve understanding of the anti-inflamma-
tory effects of melittin on inflammatory disease, and
atherosclerosis.
Methods
Cell culture and biological reagents
Human Vascular Smooth Muscle Cells (hVSMCs) were
obtained from the American Type Culture Collection
(Manassas, VA, USA). Cells were cultured in RPMI
medium (Invitrogen, Gland island, USA) containing 10%
fetal bovine serum. The cells were maintained at 37°C.
The hVSMCs were grown on culture plates to 60%-70%
confluence in complete medium containing 10% FBS for
12 hours, and then changed to serum-free medium after
washing twice with medium. Then, the cells were incu-
bated with TNF-α or melittin at various concentrations.
Protein extraction and Two-dimensional gel
electrophoresis
hVSMCs were washed three times with ice-cold PBS.
Cells were lysed with a buffer containing 5 mM EDTA,
9.5 M urea, 4% (v/v) CHAPS, 65 mM DTT and protease
inhibitors (Complete kit, Roche Diagnostics, Germany)for 1 h at 24°C. Cellular debris was removed by centrifu-
gation for 15 min at 20000 × g at 4°C. Protein samples
were stored at −70°C. Protein concentrations were quan-
tified using a commercial Bradford Kit (DC reagent kit,
Bio-Rad).
2-D electrophoresis was performed using an established
procedure [31]. Whole cell lysate (400 μg) was added to
immobilized pH 3–10 linear gradient strips (ReadyStrip
IPG strip, Bio-Rad). After finished IEF, the IPG strips
were incubated in equilibration buffer containing 37.5
mM Tris–HCl (pH 8.8), 6 M urea, 2% (w/vol) SDS, 30%
(v/v) glycerol and 2% (w/vol) DTT or 2.5% (w/vol)
iodoacetamide for 30 min. The equilibrated IPG strips
were transferred onto 12% Duracryl gels (180 × 160 ×
1.5 mm) for SDS–PAGE. We stained gels with sensitive
colloidal coomassie G-250 according to Neuhoff et al.
[32]. To check the reproducibility of the data, three inde-
pendent experiments were performed on each cell lysate.
For the differential analysis, statistical significance was es-
timated with Student’s t-test. Values of p < 0.05 were con-
sidered significant.
Protein identification
Protein identification was performed as described previ-
ously study [33]. In brief, proteins were in-gel digested
with trypsin and extracted from coomassie stained 2-D
gel pieces in according to standard procedures. After in-
gel digested, the peptides were extracted twice with 0.1%
TFA in 50% acetonitrile. Extracts were pooled and
lyophilized. The resulting lyophilized tryptic peptides
were concentrated and desalted by passing them through
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standard procedures. MS analysis was conducted with a
MALDI-TOF-TOF mass spectrometer 4700 Proteomics
Analyzer (Applied Biosystems, Framingham, MA, USA).
Data were analyzed using GPS Explorer software
(Applied Biosystem) and MASCOT software (Matrix
Science, London, UK). NCBInr and human were selected
as the database and taxonomy, respectively. Identifica-
tion was assigned to a protein spot feature if the protein
score was calculated to be greater than 50, correlating to
a confidence interval of 99%.
Protein pathway analysis
After protein identification, the accession numbers and
fold changes of the differentially expressed proteins were
tabulated in Microsoft Excel and imported into IPA
(Ingenuity System, Montain View, CA, USA). IPA is a
software application that enables to identify the bio-
logical mechanisms, pathways and functions matching a
particular dataset of proteins. IPA is based on a database
obtained by abstracting and interconnecting a large frac-
tion of the biomedical literature according to a very
strict algorithm. This database integrates protein func-
tions, cellular localization, small molecules and disease
inter-relationships. The networks are displayed graphic-
ally as nodes, representing individual proteins and edges
representing the biological relation between nodes.
Using IPA, Canonical pathway analysis utilizes well char-
acterized metabolic and cell signaling pathways which
are generated prior to data input and on which identified
proteins are overlaid.
Western blot analysis
Whole cell and nuclear lysates were prepared as previ-
ously described [31]. Cells were lysed with RIPA buffer.
(50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM DTT,
0.5% [v/v] NP 40 10 mM NaF and proteases inhibitors).
The cells were disrupted and proteins were extracted at
4°C for 30 min. The proteins were electro transferred to
PVDF membranes (Invitrogen). Detection of specific
proteins was carried out with an enhanced chemilumin-
escence western blotting kit following the manufacturer’s
(Pierce) instructions. Antibodies specific for p-ERK,
ERK, EGFR, p-EGFR, NF-κB and β-actin were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA).
Reverse transcribed–PCR-analysis
After treatment of cells with TNF-α or melittin, Total
RNA was isolated from each preparation using the
Trizol reagent (Invitrogen, Carlsbad, CA). Reverse tran-
scription was carried out using a commercial kit (Super-
script II RNase H-reverse transcriptase, Invitrogen) and
total RNA (1 μg) from hVSMCs, according to the
manufacturer's protocol. Gene expression was analyzedusing specific primers. Amplified products were resolved
by 1.0% (w/v) agarose gel electrophoresis and visualized
by staining with ethidium bromide. We quantified
the actual mRNA level of each gene by using Eagle
Sight densitometry software (Version 3.21; Stratagene,
La Jolla, CA).
Additional file
Additional file 1: Validation of the two-dimensional-PAGE data by
quantitative RT-PCR and validation of protein pathway analysis
data. A, expression of selected genes in hVSMCs respectively treated with
TNF-α and melittin for 12 h was determined by quantitative RT-PCR. Total
RNA was isolated from hVSMCs, reverse transcribed and amplified with
the specific primers indicated in under “Materials and methods.” β-actin
was used as the control. B, Total cell lysates (25 μg) and nuclear lysates
(40 μg) of hVSMCs respectively treated for 12 h with TNF-α and melittin
were separated by SDS-PAGE. Proteins were blotted onto a PVDF
membrane, probed with specific antibodies, and detected as described
under “materials and methods.”
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